| 内源性缩血管物质在糖尿病肾病形成中的变化情况及作用机制 |
| |
| 引用本文： | 安娜芹,丁选胜.内源性缩血管物质在糖尿病肾病形成中的变化情况及作用机制[J].金属学报,2008,13(5):589-595. |
| |
| 作者姓名： | 安娜芹 丁选胜 |
| |
| 作者单位： | 中国药科大学临床药学教研室, 南京210009, 江苏 |
| |
| 摘 要： | 糖尿病肾病(diabetic nephropathy, DN) 是糖尿病(diabetes mellitus, DM) 最主要的微血管病变之一。一系列血管活性物质参与了DN 的形成过程。本文综述近年来其中内源性缩血管活性物质在DN 发生发展过程中的变化情况及其作用机制, 并展望了该疾病潜在的治疗方向。
|
| 关 键 词： | 血管紧张素Ⅱ 内皮素-1 血栓素A2 尿压素Ⅱ 加压素 糖尿病肾病 机制 |
| 收稿时间： | 2008-03-18 |
| 修稿时间： | 2008-04-22 |
Mechanisms and changes of endogenous vasoconstrictive substances in development of diabetic nephropathy |
| |
| AN Na-qin,DING Xuan-sheng.Mechanisms and changes of endogenous vasoconstrictive substances in development of diabetic nephropathy[J].Acta Metallurgica Sinica,2008,13(5):589-595. |
| |
| Authors: | AN Na-qin DING Xuan-sheng |
| |
| Affiliation: | Teaching and Research Section of Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China |
| |
| Abstract: | Diabetic nephropathy (DN) is one of the most common microangiopathy complications in diabetes mellitus (DM). Many vasoactive substances are related to the development of DN. This article reviewed the mechanisms and changes of endogenous vasoconstrictive substances in the development of DN, also expected the possible treatment methods of DN. |
| |
| Keywords: | angiotensin Ⅱ endothelin-1 thromboxan A2 urotensin Ⅱ vasopressin diabetic nephropathy mechanism |
|
| 点击此处可从《金属学报》浏览原始摘要信息 |
|
点击此处可从《金属学报》下载全文 |
